SE441360B - Forfarande for framstellning av fosfonsyraderivat - Google Patents

Forfarande for framstellning av fosfonsyraderivat

Info

Publication number
SE441360B
SE441360B SE7708592A SE7708592A SE441360B SE 441360 B SE441360 B SE 441360B SE 7708592 A SE7708592 A SE 7708592A SE 7708592 A SE7708592 A SE 7708592A SE 441360 B SE441360 B SE 441360B
Authority
SE
Sweden
Prior art keywords
procedure
acid derivatives
phosphonic acid
preparing phosphonic
preparing
Prior art date
Application number
SE7708592A
Other languages
English (en)
Other versions
SE7708592L (sv
Inventor
T Kamiya
M Hashimoto
K Hemmi
H Takeno
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of SE7708592L publication Critical patent/SE7708592L/sv
Publication of SE441360B publication Critical patent/SE441360B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3826Acyclic unsaturated acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7708592A 1976-07-27 1977-07-26 Forfarande for framstellning av fosfonsyraderivat SE441360B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB3133976 1976-07-27
GB4222276 1976-10-11
GB31339/76A GB1580899A (en) 1976-07-27 1977-06-20 Hydroxyaminohydrocarbonphosphonic acid derivatives and production and use thereof

Publications (2)

Publication Number Publication Date
SE7708592L SE7708592L (sv) 1978-01-28
SE441360B true SE441360B (sv) 1985-09-30

Family

ID=27258468

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7708592A SE441360B (sv) 1976-07-27 1977-07-26 Forfarande for framstellning av fosfonsyraderivat

Country Status (21)

Country Link
US (1) US4182758A (sv)
JP (1) JPS5340720A (sv)
AR (1) AR226522A1 (sv)
AT (2) AT367064B (sv)
CA (1) CA1091241A (sv)
CH (5) CH640862A5 (sv)
DE (2) DE2733658A1 (sv)
DK (1) DK149609C (sv)
ES (3) ES461084A1 (sv)
FI (1) FI64377C (sv)
FR (1) FR2474505A1 (sv)
GB (1) GB1580899A (sv)
GR (1) GR61140B (sv)
HU (1) HU182023B (sv)
IE (1) IE45536B1 (sv)
NL (1) NL7708325A (sv)
NO (1) NO157504C (sv)
OA (1) OA05725A (sv)
PH (1) PH14401A (sv)
PT (1) PT66854B (sv)
SE (1) SE441360B (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4084953A (en) * 1977-03-09 1978-04-18 Monsanto Company N-hydroxy-N-phosphonomethylglycines and the herbicidal use thereof
US4210635A (en) * 1978-02-15 1980-07-01 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
US4268503A (en) * 1978-09-14 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
US4693742A (en) * 1983-12-20 1987-09-15 Rohm And Hass Company Herbicidal hydroxyamino phosphonic acids and derivatives
US5189030A (en) * 1985-06-11 1993-02-23 Ciba-Geigy Corporation 1-amino-2-phenylethanephosphonic acids as microbiocides
JPH0340299U (sv) * 1989-08-31 1991-04-18
DE19825585A1 (de) * 1998-04-14 1999-10-21 Hassan Jomaa Verwendung von Aminohydrocarbylphosphonsäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen, die durch Parasiten, Pilze oder Viren hervorgerufen werden
TR200002965T2 (tr) 1998-04-14 2001-05-21 Jomaa,Hassan Enfeksiyonların terapötik ve profilaktik tedavisi için organofosforlu terkiplerin kullanımı
DE19843223A1 (de) * 1998-09-22 2000-03-30 Hassan Jomaa Phosphororganische Verbindungen und ihre Verwendung
US6753324B2 (en) 1998-07-15 2004-06-22 Hassan Jomaa Phosphorous organic compounds and their use
AP2001002051A0 (en) 1998-07-15 2001-03-31 Hassan Jomaa Phosphorous organic compounds and their use.
AU5034899A (en) * 1998-07-15 2000-02-07 Jomaa Hassan Drugs containing phosphoric acid derivatives as active ingredient and their use
DE19854403A1 (de) * 1998-11-25 2000-05-31 Hassan Jomaa Phosphororganische Verbindungen und ihre Verwendung
WO2001060829A1 (de) * 2000-02-18 2001-08-23 Jomaa Pharmaka Gmbh Phosphororganische verbindungen und ihre verwendung
DE10035189A1 (de) * 2000-07-20 2002-02-21 Hassan Jomaa Arzneimittel zur oralen Applikation mit einem Gehalt an 3-N-Formylhydroxylaminopropylphosphonsäureestern oder 3-N-Acetylhydroxylaminopropylphosphonsäureestern als Wirkstoff
US20080300222A1 (en) * 2005-10-06 2008-12-04 Innate Pharma Phosphoantigen Salts Of Organic Bases And Methods For Their Crystallization
WO2007088878A1 (ja) * 2006-01-31 2007-08-09 Api Corporation ベンゾアゼピノン類の製造方法
AU2009276343A1 (en) 2008-08-01 2010-02-04 Bioxiness Pharmaceuticals, Inc. Methionine analogs and methods of using same
EP2404601A1 (en) 2010-07-06 2012-01-11 BioAgency AG New drug combinations for the treatment of Malaria
EP2725029A1 (en) * 2012-10-29 2014-04-30 Laboratoire Biodim New antibacterial compounds and biological applications thereof
WO2019246119A1 (en) * 2018-06-18 2019-12-26 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Antibiotics for veterinary staphylococcal infections
EP4045056A1 (de) 2019-10-19 2022-08-24 DMG Deutsche Malaria GmbH Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit clindamycin und artesunat
EP3960176A1 (en) 2020-08-26 2022-03-02 DMG Deutsche Malaria GmbH Piperaquine and related drug combinations for use in the treatment of covid-19

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6905272A (sv) 1968-05-15 1969-11-18
US3764677A (en) * 1971-06-25 1973-10-09 Gates Rubber Co Diethyl betaaminoethylphosphonate as an antimicrobial agent

Also Published As

Publication number Publication date
JPS613799B2 (sv) 1986-02-04
PT66854A (en) 1977-08-01
AT367430B (de) 1982-07-12
FI772280A (sv) 1978-01-28
GB1580899A (en) 1980-12-10
ES479211A1 (es) 1979-12-16
NO772652L (no) 1978-01-30
DE2760320C2 (sv) 1988-11-03
IE45536L (en) 1978-01-27
GR61140B (en) 1978-09-23
ATA550977A (de) 1981-10-15
FI64377B (fi) 1983-07-29
DK337877A (da) 1978-01-28
ES461084A1 (es) 1978-12-01
US4182758A (en) 1980-01-08
CH647807A5 (de) 1985-02-15
NO157504B (no) 1987-12-21
DK149609C (da) 1987-02-09
CA1091241A (en) 1980-12-09
DK149609B (da) 1986-08-11
AR226522A1 (es) 1982-07-30
JPS5340720A (en) 1978-04-13
DE2733658A1 (de) 1978-02-09
ES471822A1 (es) 1979-10-16
HU182023B (en) 1983-12-28
SE7708592L (sv) 1978-01-28
NL7708325A (nl) 1978-01-31
CH640862A5 (de) 1984-01-31
FR2474505B1 (sv) 1984-01-27
PT66854B (en) 1978-12-28
FI64377C (fi) 1983-11-10
OA05725A (fr) 1981-05-31
IE45536B1 (en) 1982-09-22
PH14401A (en) 1981-06-25
AT367064B (de) 1982-05-25
CH646978A5 (de) 1984-12-28
NO157504C (no) 1988-03-30
FR2474505A1 (fr) 1981-07-31
CH646980A5 (de) 1984-12-28
ATA564879A (de) 1981-11-15
DE2733658C2 (sv) 1987-06-25
CH646979A5 (de) 1984-12-28

Similar Documents

Publication Publication Date Title
SE442295B (sv) Forfarande for framstellning av 4-amino-5-en-hexansyra
SE436572B (sv) Forfarande for framstellning av androstadien-17-karbonsyraestrar
SE441360B (sv) Forfarande for framstellning av fosfonsyraderivat
SE420199B (sv) Forfarande for framstellning av 16-oxiderade prostansyraderivat
SE440501B (sv) Forfarande for framstellning av substituerade fenylamidoximer
SE434394B (sv) Analogiforfarande for framstellning av kinolonalkansyraderivat
TR19755A (tr) Tereftalik asidin hazirlanmasina mahsus usul
NO773548L (no) Fremgangsmaate for fremstilling av spiro-hydantoinderivater
SE431652B (sv) Forfarande for framstellning av 7beta-amino-3cefem-3ol-4-karboxylsyraderivat
SE440772B (sv) Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat
SE433212B (sv) Forfarande for framstellning av 4-hydroxi-aporfin-derivat
SE431871B (sv) Forfarande for framstellning av 2-brom-6-fluor-n-2-imidazolidinylidenbensamin
DK455877A (da) Fremgangsmaade til fremstilling af phenyleddikesyrederivater
SE7802609L (sv) Forfarande for framstellning av 1-azaxanton-3-karboxylsyraderivat
SE433219B (sv) Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
NO791604L (no) Fremangsmaate for fremstilling av di-o-n-alkyl-glycerolderivater
SE443140B (sv) Forfarande for framstellning av karbostyrilderivat
SE433220B (sv) Forfarande for framstellning av nya pregnan-derivat
NO821484L (no) Fremgangsmaate for fremstilling av fosfonsyrederivater
SE421125B (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO147186C (no) Fremgangsmaate for fremstilling av substituerte purinforbindelser
NO773073L (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater
SE440903B (sv) Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-aminopropaner
SE418287B (sv) Forfarande for framstellning av guajakol-p-isobutyl-hydratropat
SE434157B (sv) Forfarande for framstellning av 6-aminopenicillansyra

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7708592-6

Effective date: 19950210

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7708592-6

Format of ref document f/p: F